Source-linked briefing Health

Trial Suggests Chemoradiotherapy Could Spare Most Early Rectal Cancer Patients From Surgery

Trial Suggests Chemoradiotherapy Could Spare Most Early Rectal Cancer Patients From Surgery

A landmark trial reports that chemoradiotherapy could help about four in five early-stage rectal cancer patients avoid major surgery. The findings point to a potential shift in treatment, pending longer-term outcomes and broader validation.

Original headline

New Rectal Cancer Treatment Could Avoid Major Surgery